Abstract

Summary Objective We determined the effect of obesity on early post-ischemic blood–brain barrier (BBB) disruption. Methods Male C57BL/6J mice were fed a high-fat diet (HFD) or standard chow for 16 weeks. Transient focal cerebral ischemia was induced by directly ligating the middle cerebral artery for 2 h. Early BBB disruption was assessed by measuring Evans Blue and sodium fluorescein extravasation at 3 h of reperfusion. Results Obesity produced an increase in cerebral vasodilation/hyperaemia during reperfusion. N(omega)-propyl-L-arginine and 7-nitroindazole (neuronal nitric oxide synthase inhibitors) failed to alter the cerebral vasodilation/hyperaemia in lean mice, but significantly inhibited the cerebral vasodilation/hyperaemia in obese mice. The magnitude of early post-ischemic BBB disruption was significantly greater in obese mice compared with lean mice. Topical treatment with N(omega)-propyl-L-arginine, 7-nitroindazole or N(omega)-propyl-L-arginine, 7-nitroindazole (a non-specific nitric oxide synthase [NOS] inhibitor) completely abolished the BBB disruption in lean mice, but only partially suppressed the BBB disruption in obese mice. Furthermore, a reduced matrix metallopeptidase (MMP)-9 activity and increased endothelial NOS accompanied with unchanged protein expression of tight/adherens junctions were found in cerebral cortex of obese mice. Conclusions Our findings suggest that obesity exacerbates early post-ischemic BBB disruption via a mechanism independent of MMP or NOS.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.